| Prevalence in controls, % | 2 copies | 1 or 0 copies | |||
---|---|---|---|---|---|---|
 |  | Case/Control | AOR | Case/Control | AOR (95% CI) | p |
HAP1 (CAT)a | 73.3 | 159/244 | 1.00 | 107/200 | 0.65 (0.44-0.95) | 0.02 |
ApoE e4 non-carriers | Â | 99/206 | 1.00 | 62/170 | 0.57 (0.36-0.91) | 0.02 |
ApoE e4 carriers | Â | 59/37 | 1.00 | 45/29 | 0.85 (0.42-1.76) | 0.67 |
 | Prevalence in controls, % | 0 copies | 1 or 2 copies | |||
 |  | Case/Control | AOR | Case/Control | AOR (95% CI) | p |
HAP2 (GGC) | 17.8 | 263/439 | 1.00 | 3/5 | 1.10 (0.16-7.58) | 0.92 |
HAP3 (GAC) | 8.1 | 260/442 | 1.00 | 6/2 | 2.56 (0.39-16.95) | 0.33 |